Acknowledgement
This research was funded by grants from the National Research Foundation of Korea (NRF-2019R1A2C1086949).
References
- Anczukow, O. and Krainer, A.R. (2016). Splicing-factor alterations in cancers. RNA 22, 1285-1301. https://doi.org/10.1261/rna.057919.116
- Antoniou, N., Lagopati, N., Balourdas, D.I., Nikolaou, M., Papalampros, A., Vasileiou, P.V.S., Myrianthopoulos, V., Kotsinas, A., Shiloh, Y., Liontos, M., et al. (2019). The role of E3, E4 ubiquitin ligase (UBE4B) in human pathologies. Cancers (Basel) 12, 62. https://doi.org/10.3390/cancers12010062
- Bernier, F.P., Caluseriu, O., Ng, S., Schwartzentruber, J., Buckingham, K.J., Innes, A.M., Jabs, E.W., Innis, J.W., Schuette, J.L., Gorski, J.L., et al. (2012). Haploinsufficiency of SF3B4, a component of the pre-mRNA spliceosomal complex, causes Nager syndrome. Am. J. Hum. Genet. 90, 925-933. https://doi.org/10.1016/j.ajhg.2012.04.004
- Cassina, M., Cerqua, C., Rossi, S., Salviati, L., Martini, A., Clementi, M., and Trevisson, E. (2017). A synonymous splicing mutation in the SF3B4 gene segregates in a family with highly variable Nager syndrome. Eur. J. Hum. Genet. 25, 371-375. https://doi.org/10.1038/ejhg.2016.176
- Castori, M., Bottillo, I., D'Angelantonio, D., Morlino, S., De Bernardo, C., Scassellati Sforzolini, G., Silvestri, E., and Grammatico, P. (2014). A 22-week-old fetus with Nager syndrome and congenital diaphragmatic hernia due to a novel SF3B4 mutation. Mol. Syndromol. 5, 241-244. https://doi.org/10.1159/000365769
- Champion-Arnaud, P. and Reed, R. (1994). The prespliceosome components SAP 49 and SAP 145 interact in a complex implicated in tethering U2 snRNP to the branch site. Genes Dev. 8, 1974-1983. https://doi.org/10.1101/gad.8.16.1974
- de Miguel, F.J., Sharma, R.D., Pajares, M.J., Montuenga, L.M., Rubio, A., and Pio, R. (2014). Identification of alternative splicing events regulated by the oncogenic factor SRSF1 in lung cancer. Cancer Res. 74, 1105-1115.
- Ding, J., Li, C., Cheng, Y., Du, Z., Wang, Q., Tang, Z., Song, C., Xia, Q., Bai, W., Lin, L., et al. (2021). Alterations of RNA splicing patterns in esophagus squamous cell carcinoma. Cell Biosci. 11, 36. https://doi.org/10.1186/s13578-021-00546-z
- Drozniewska, M., Kilby, M.D., Vogt, J., Togneri, F., Quinlan-Jones, E., Reali, L., Allen, S., and McMullan, D. (2020). Second-trimester prenatal diagnosis of Nager syndrome with a deletion including SF3B4 detected by chromosomal microarray. Clin. Case Rep. 8, 508-511. https://doi.org/10.1002/ccr3.2509
- Du, C., Wu, H., and Leng, R.P. (2016). UBE4B targets phosphorylated p53 at serines 15 and 392 for degradation. Oncotarget 7, 2823-2836 https://doi.org/10.18632/oncotarget.6555
- Gozani, O., Feld, R., and Reed, R. (1996). Evidence that sequenceindependent binding of highly conserved U2 snRNP proteins upstream of the branch site is required for assembly of spliceosomal complex A. Genes Dev. 10, 233-243. https://doi.org/10.1101/gad.10.2.233
- Guo, R., Li, Y., Ning, J., Sun, D., Lin, L., and Liu, X. (2013). HnRNP A1/A2 and SF2/ASF regulate alternative splicing of interferon regulatory factor-3 and affect immunomodulatory functions in human non-small cell lung cancer cells. PLoS One 8, e62729. https://doi.org/10.1371/journal.pone.0062729
- Haupt, Y., Maya, R., Kazaz, A., and Oren, M. (1997). Mdm2 promotes the rapid degradation of p53. Nature 387, 296-299. https://doi.org/10.1038/387296a0
- Havugimana, P.C., Hart, G.T., Nepusz, T., Yang, H., Turinsky, A.L., Li, Z., Wang, P.I., Boutz, D.R., Fong, V., Phanse, S., et al. (2012). A census of human soluble protein complexes. Cell 150, 1068-1081. https://doi.org/10.1016/j.cell.2012.08.011
- Hayata, K., Masuyama, H., Eto, E., Mitsui, T., Tamada, S., Eguchi, T., Maki, J., Tani, K., Ohira, A., Washio, Y., et al. (2019). A case of Nager syndrome diagnosed before birth. Acta Med. Okayama 73, 273-277.
- Heuze, M.L., Lamsoul, I., Moog-Lutz, C., and Lutz, P.G. (2008). Ubiquitinmediated proteasomal degradation in normal and malignant hematopoiesis. Blood Cells Mol. Dis. 40, 200-210. https://doi.org/10.1016/j.bcmd.2007.07.011
- Huang, X.Q., Hao, S., Zhou, Z.Q., Huang, B., Fang, J.Y., Tang, Y., Zhang, J.H., and Xia, J.C. (2020). The roles of ubiquitination factor E4B (UBE4B) in the postoperative prognosis of patients with renal cell carcinoma and in renal tumor cells growth and metastasis. Onco Targets Ther. 13, 185-197. https://doi.org/10.2147/OTT.S229577
- Iguchi, T., Komatsu, H., Masuda, T., Nambara, S., Kidogami, S., Ogawa, Y., Hu, Q., Saito, T., Hirata, H., Sakimura, S., et al. (2016). Increased copy number of the gene encoding SF3B4 indicates poor prognosis in hepatocellular carcinoma. Anticancer Res. 36, 2139-2144.
- Juven-Gershon, T. and Oren, M. (1999). Mdm2: the ups and downs. Mol. Med. 5, 71-83. https://doi.org/10.1007/BF03402141
- Kidogami, S., Iguchi, T., Sato, K., Yoshikawa, Y., Hu, Q., Nambara, S., Komatsu, H., Ueda, M., Kuroda, Y., Masuda, T., et al. (2020). SF3B4 plays an oncogenic role in esophageal squamous cell carcinoma. Anticancer Res. 40, 2941-2946. https://doi.org/10.21873/anticanres.14272
- Koegl, M., Hoppe, T., Schlenker, S., Ulrich, H.D., Mayer, T.U., and Jentsch, S. (1999). A novel ubiquitination factor, E4, is involved in multiubiquitin chain assembly. Cell 96, 635-644. https://doi.org/10.1016/S0092-8674(00)80574-7
- Koh, E.Y., You, J.E., Jung, S.H., and Kim, P.H. (2020). Biological functions and identification of novel biomarker expressed on the surface of breast cancer-derived cancer stem cells via proteomic analysis. Mol. Cells 43, 384-396.
- Lai, Z., Ferry, K.V., Diamond, M.A., Wee, K.E., Kim, Y.B., Ma, J., Yang, T., Benfield, P.A., Copeland, R.A., and Auger, K.R. (2001). Human mdm2 mediates multiple mono-ubiquitination of p53 by a mechanism requiring enzyme isomerization. J. Biol. Chem. 276, 31357-31367. https://doi.org/10.1074/jbc.M011517200
- Lee, J., Seo, G., Hur, W., Yoon, S.K., Nam, S.W., and Lee, J.H. (2020). SRSF3 depletion leads to an increase in SF3B4 expression in SNU-368 HCC cells. Anticancer Res. 40, 2033-2042. https://doi.org/10.21873/anticanres.14160
- Lim, K.L., Chew, K.C., Tan, J.M., Wang, C., Chung, K.K., Zhang, Y., Tanaka, Y., Smith, W., Engelender, S., Ross, C.A., et al. (2005). Parkin mediates nonclassical, proteasomal-independent ubiquitination of synphilin-1: implications for Lewy body formation. J. Neurosci. 25, 2002-2009. https://doi.org/10.1523/JNEUROSCI.4474-04.2005
- Liu, Z., Li, W., Pang, Y., Zhou, Z., Liu, S., Cheng, K., Qin, Q., Jia, Y., and Liu, S. (2018). SF3B4 is regulated by microRNA-133b and promotes cell proliferation and metastasis in hepatocellular carcinoma. EBioMedicine 38, 57-68. https://doi.org/10.1016/j.ebiom.2018.10.067
- Lv, J., He, Y., Li, L., and Wang, Z. (2020). Alternative splicing events and splicing factors are prognostic in adrenocortical carcinoma. Front. Genet. 11, 918. https://doi.org/10.3389/fgene.2020.00918
- Matsumoto, M., Yada, M., Hatakeyama, S., Ishimoto, H., Tanimura, T., Tsuji, S., Kakizuka, A., Kitagawa, M., and Nakayama, K.I. (2004). Molecular clearance of ataxin-3 is regulated by a mammalian E4. EMBO J. 23, 659-669. https://doi.org/10.1038/sj.emboj.7600081
- Memarzadeh, K., Savage, D.J., and Bean, A.J. (2019). Low UBE4B expression increases sensitivity of chemoresistant neuroblastoma cells to EGFR and STAT5 inhibition. Cancer Biol. Ther. 20, 1416-1429. https://doi.org/10.1080/15384047.2019.1647049
- Meza, R., Meernik, C., Jeon, J., and Cote, M.L. (2015). Lung cancer incidence trends by gender, race and histology in the United States, 1973- 2010. PLoS One 10, e0121323. https://doi.org/10.1371/journal.pone.0121323
- Mohanty, S., Han, T., Choi, Y.B., Lavorgna, A., Zhang, J., and Harhaj, E.W. (2020). The E3/E4 ubiquitin conjugation factor UBE4B interacts with and ubiquitinates the HTLV-1 Tax oncoprotein to promote NF-kappaB activation. PLoS Pathog. 16, e1008504. https://doi.org/10.1371/journal.ppat.1008504
- Shen, Q., Eun, J.W., Lee, K., Kim, H.S., Yang, H.D., Kim, S.Y., Lee, E.K., Kim, T., Kang, K., Kim, S., et al. (2018). Barrier to autointegration factor 1, procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3, and splicing factor 3b subunit 4 as early-stage cancer decision markers and drivers of hepatocellular carcinoma. Hepatology 67, 1360-1377. https://doi.org/10.1002/hep.29606
- Shen, Q. and Nam, S.W. (2018). SF3B4 as an early-stage diagnostic marker and driver of hepatocellular carcinoma. BMB Rep. 51, 57-58. https://doi.org/10.5483/BMBRep.2018.51.2.021
- Subramanian, M., Hyeon, S.J., Das, T., Suh, Y.S., Kim, Y.K., Lee, J.S., Song, E.J., Ryu, H., and Yu, K. (2021). UBE4B, a microRNA-9 target gene, promotes autophagy-mediated Tau degradation. Nat. Commun. 12, 3291. https://doi.org/10.1038/s41467-021-23597-9
- Sumithra, B., Jayanthi, V., Manne, H.C., Gunda, R., Saxena, U., and Das, A.B. (2020). Antibody-based biosensor to detect oncogenic splicing factor Sam68 for the diagnosis of lung cancer. Biotechnol. Lett. 42, 2501-2509. https://doi.org/10.1007/s10529-020-02951-9
- Treiber, T., Treiber, N., Plessmann, U., Harlander, S., Daiss, J.L., Eichner, N., Lehmann, G., Schall, K., Urlaub, H., and Meister, G. (2017). A compendium of RNA-binding proteins that regulate microRNA biogenesis. Mol. Cell 66, 270-284.e13. https://doi.org/10.1016/j.molcel.2017.03.014
- Ueno, T., Taga, Y., Yoshimoto, R., Mayeda, A., Hattori, S., and OgawaGoto, K. (2019). Component of splicing factor SF3b plays a key role in translational control of polyribosomes on the endoplasmic reticulum. Proc. Natl. Acad. Sci. U. S. A. 116, 9340-9349. https://doi.org/10.1073/pnas.1901742116
- Wang, L., Zhang, Z., Li, Y., Wan, Y., and Xing, B. (2020). Integrated bioinformatic analysis of RNA binding proteins in hepatocellular carcinoma. Aging (Albany N.Y.) 13, 2480-2505.
- Watanabe, H., Shionyu, M., Kimura, T., Kimata, K., and Watanabe, H. (2007). Splicing factor 3b subunit 4 binds BMPR-IA and inhibits osteochondral cell differentiation. J. Biol. Chem. 282, 20728-20738. https://doi.org/10.1074/jbc.M703292200
- Weng, C., Chen, Y., Wu, Y., Liu, X., Mao, H., Fang, X., Li, B., Wang, L., Guan, M., Liu, G., et al. (2019). Silencing UBE4B induces nasopharyngeal carcinoma apoptosis through the activation of caspase3 and p53. Onco Targets Ther. 12, 2553-2561. https://doi.org/10.2147/OTT.S196132
- Wu, H., Pomeroy, S.L., Ferreira, M., Teider, N., Mariani, J., Nakayama, K.I., Hatakeyama, S., Tron, V.A., Saltibus, L.F., Spyracopoulos, L., et al. (2011). UBE4B promotes Hdm2-mediated degradation of the tumor suppressor p53. Nat. Med. 17, 347-355. https://doi.org/10.1038/nm.2283
- Xu, W., Huang, H., Yu, L., and Cao, L. (2015). Meta-analysis of gene expression profiles indicates genes in spliceosome pathway are upregulated in hepatocellular carcinoma (HCC). Med. Oncol. 32, 96. https://doi.org/10.1007/s12032-014-0425-6
- Yan, J., Zhang, D., Han, Y., Wang, Z., and Ma, C. (2019). Antitumor activity of SR splicing-factor 5 knockdown by downregulating pyruvate kinase M2 in non-small cell lung cancer cells. J. Cell. Biochem. 120, 17303-17311. https://doi.org/10.1002/jcb.28992
- Yang, S., Hwang, S., Kim, M., Seo, S.B., Lee, J.H., and Jeong, S.M. (2018). Mitochondrial glutamine metabolism via GOT2 supports pancreatic cancer growth through senescence inhibition. Cell Death Dis. 9, 55. https://doi.org/10.1038/s41419-017-0089-1
- Yun, H.H., Jung, S.Y., Park, B.W., Ko, J.S., Yoo, K., Yeo, J., Kim, H.L., Park, H.J., Youn, H.J., and Lee, J.H. (2021). An adult mouse model of dilated cardiomyopathy caused by inducible cardiac-specific Bis deletion. Int. J. Mol. Sci. 22, 1343. https://doi.org/10.3390/ijms22031343
- Yun, H.H., Kim, S., Kuh, H.J., and Lee, J.H. (2020). Downregulation of BIS sensitizes A549 cells for digoxin-mediated inhibition of invasion and migration by the STAT3-dependent pathway. Biochem. Biophys. Res. Commun. 524, 643-648. https://doi.org/10.1016/j.bbrc.2020.01.154
- Zage, P.E., Sirisaengtaksin, N., Liu, Y., Gireud, M., Brown, B.S., Palla, S., Richards, K.N., Hughes, D.P., and Bean, A.J. (2013). UBE4B levels are correlated with clinical outcomes in neuroblastoma patients and with altered neuroblastoma cell proliferation and sensitivity to epidermal growth factor receptor inhibitors. Cancer 119, 915-923. https://doi.org/10.1002/cncr.27785
- Zhang, S., Bao, Y., Shen, X., Pan, Y., Sun, Y., Xiao, M., Chen, K., Wei, H., Zuo, J., Saffen, D., et al. (2020). RNA binding motif protein 10 suppresses lung cancer progression by controlling alternative splicing of eukaryotic translation initiation factor 4H. EBioMedicine 61, 103067. https://doi.org/10.1016/j.ebiom.2020.103067
- Zhang, X.F., Pan, Q.Z., Pan, K., Weng, D.S., Wang, Q.J., Zhao, J.J., He, J., Liu, Q., Wang, D.D., Jiang, S.S., et al. (2016). Expression and prognostic role of ubiquitination factor E4B in primary hepatocellular carcinoma. Mol. Carcinog. 55, 64-76. https://doi.org/10.1002/mc.22259
- Zhang, Y., Lv, Y., Zhang, Y., and Gao, H. (2014). Regulation of p53 level by UBE4B in breast cancer. PLoS One 9, e90154. https://doi.org/10.1371/journal.pone.0090154
- Zhao, J. and Yang, L. (2020). Broad-spectrum next-generation sequencingbased diagnosis of a case of Nager syndrome. J. Clin. Lab. Anal. 34, e23426. https://doi.org/10.1002/jcla.23426
- Zhou, W., Ma, N., Jiang, H., Rong, Y., Deng, Y., Feng, Y., Zhu, H., Kuang, T., Lou, W., Xie, D., et al. (2017). SF3B4 is decreased in pancreatic cancer and inhibits the growth and migration of cancer cells. Tumour Biol. 39, 1010428317695913.